Immunovant Inc.

NASDAQ: IMVT · Real-Time Price · USD
15.17
-0.03 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
15.22
0.33%
After-hours: Aug 15, 2025, 06:46 PM EDT

Immunovant Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Net Income
-120.61M -106.45M -111.12M -109.12M -87.15M -75.32M -51.42M -58.66M -73.94M -59.43M -63.23M -47.93M -40.37M -47.17M -41.38M -37.7M -30.47M -28.16M -31.78M -20.79M -26.71M
Depreciation & Amortization
107K 109K 99K 89K 80K 64K 525K 56K 53K 341K 49K 46K 44K 39K 33K 28K 26K 22K 19K 14K 10K
Stock-Based Compensation
18.51M 11.69M 11.65M 12.69M 13.46M 9.68K 10.2K 10.5K 10.69K 7.55K 8.86K 8.05K 7.69M 11.86M 10.16M 8.36M 3.86M 5.49M 5.99M 3.36M 3.98M
Other Working Capital
-6.17M -13.53M -586K -2.12M -9.46M 6.35M -2.81M 7.2M -24.87M 8.38M -1.82M 2.98M -15.02M -12.83M 185K 7.69M 3.85M 361K 5.8M -4.78M 1.93M
Other Non-Cash Items
24K 22K 23K 22K 6.88M 10.79M 11.1M 293K 25.16M 287K 284K 281K 279K 275K -460K 1.02M 274K 219K 283K 279K 152K
Deferred Income Tax
n/a n/a n/a n/a n/a 36.14M -11.27M n/a -24.87M n/a n/a n/a n/a n/a n/a -571K 571K -765K 689K -232K 26K
Change in Working Capital
-15.44M -16.01M -1.04M 7.67M -2.65M 5.63M -6.25M -12.28M 15.54M -4.25M 7.59M 19.26M -33.46M 2.04M -242K 8.82M 4.53M 698K 1.98M -6.85M 8.74M
Operating Cash Flow
-117.41M -110.64M -100.39M -88.65M -76.2M -59.7M -47.1M -60.06M -47.37M -55.79M -46.4M -20.19M -65.82M -32.96M -31.89M -20.05M -21.21M -22.5M -22.82M -24.22M -13.8M
Capital Expenditures
n/a -201K -180K -196K -182K -150K -131K -34K -45K -26K -98K -31K -42K -118K -74K -44K -18K -95K -29K -39K -47K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a -201K -180K -196K -182K -150K -131K -34K -45K -26K -98K -31K -42K -118K -74K -44K -18K -95K -29K -39K -47K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -202K n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a 686K 1.54M 469.84M 148K 890K 233K 70.63M n/a 21K 200M n/a 200.04M 91K 763K 446K -201K 193.55M
Financial Cash Flow
2.92M 450.61M 2.46M 730K 686K 1.54M 469.84M 148K 890K 233K 70.63M n/a 21K n/a n/a 200.04M 91K 763K 446K 188.35M 193.55M
Net Cash Flow
-115.06M 339.29M -98.26M -87.06M -75.36M -55.57M -321.35M -60.03M -46.57M -56.08M 26.84M -21.43M -66.61M -33.19M -31.95M 179.95M -21.14M -21.83M -22.4M 164.09M 179.71M
Free Cash Flow
-117.41M -110.84M -100.57M -88.84M -76.38M -59.85M -47.23M -60.09M -47.41M -55.82M -46.49M -20.22M -65.86M -33.07M -31.97M -20.09M -21.23M -22.59M -22.84M -24.26M -13.85M